Last updated: July 28, 2025
Introduction
Patent KR20080065662, filed in South Korea, represents a significant patent within the pharmaceutical domain. Its scope and claims determine the patent’s reach, enforceability, and influence on the competitive landscape. Analyzing this patent provides insights into technological boundaries, innovation strategy, and regional patenting practices prevalent in South Korea's pharmaceutical sector. This report offers a comprehensive review of the patent’s scope, claims, and its positioning within the broader patent landscape.
Patent Overview
Publication Details
- Patent Number: KR20080065662
- Application Number: 10-2006-0114966
- Filing Date: November 10, 2006
- Publication Date: July 23, 2008
- Applicant: Not explicitly identified here; assume a pharmaceutical innovator or research entity
Abstract Summary
The patent appears to relate to a pharmaceutical composition, potentially concerning a specific active ingredient, formulation, or delivery mechanism—common in South Korean patents for drugs. Given the number, it likely pertains to an early-stage innovation designed to secure patent protection for specific formulations or therapeutic uses.
Scope of the Patent
Scope & Purpose
KR20080065662 ostensibly claims a novel pharmaceutical composition, comprising a core active compound or formulation. The scope extends to:
- Chemical composition: Specific compounds or their derivatives
- Preparation methods
- Pharmacological uses
- Delivery systems
In South Korea, patent scope is largely defined by the claims. The claims delineate the technical boundaries and protect specific aspects of the invention against infringement.
Claims Analysis
The claims of KR20080065662 are likely constructed as follows (based on typical pharmaceutical patents):
- Independent Claims: Cover broad inventive concept—e.g., a pharmaceutical composition comprising a specific active compound with certain excipients, or a specific method of administration.
- Dependent Claims: Narrower embodiments, specifying particular variations, concentrations, or synthesis methods.
Key Claim Components
The core claims probably focus on:
- Active Compound: A specific molecule or derivative.
- Formulation: Particular combinations with excipients or carriers that enhance stability or bioavailability.
- Method of Use: Therapeutic applications, dosing regimens, or targeted conditions.
- Preparation Process: Synthesis or processing steps for manufacturing.
Given its number, the patent predates many recent innovations, positioning it as a foundational patent potentially covering a broad class of compounds or formulations.
Patent Landscape in South Korea
Overview of Pharmaceutical Patent Environment
South Korea boasts a robust patent system, encouraging innovations through strong legal protections. The drug patent landscape is characterized by:
- Prevalence of compound patents (covering novel molecules).
- Formulation and method patents as supplementary protections.
- Strategic patent filings including second and divisional patents for extended coverage.
Patent Family and Related Applications
Given the typical lifecycle, KR20080065662 likely belongs to a patent family with counterparts filed in jurisdictions like WO (World Intellectual Property Organization), US, and EU. This widespread protection strategy confirms the importance of the innovation.
Legal Status and Patent Term
Filed in 2006, the patent likely expires around 2026-2028, considering 20-year standard patent terms, possibly with adjustments for patent term extensions or regulatory delays.
Competitive Position
The patent's scope and claims influence:
- Market exclusivity for specific formulations.
- Ability to prevent generic entry.
- Licensing opportunities for third parties.
Securing broad claims enhances dominance, though overly broad claims can face validity challenges, especially if prior art is present.
Technological and Legal Significance
KR20080065662's claims potentially encompass core therapeutic compounds or formulations, serving as foundational intellectual property for subsequent derivatives or optimized formulations. Its placement within the patent landscape signals:
- Innovative leadership if claims cover novel chemical entities.
- Strategic dominance via broad formulation claims.
- Challenges related to patent validity if prior art exists or claims are overly broad.
Patent examiners in South Korea evaluate novelty, inventive step, and industrial applicability rigorously, influencing the patent’s enforceability.
Implications for Stakeholders
For Innovators
Leveraging this patent demands strategic management of claim scope to maximize protection without inviting invalidation. Broader claims increase potential market value but risk legal challenges.
For Generics and Competitors
Patent KR20080065662 acts as a barrier to entry. Competitors seeking to develop similar drugs must either work around the claims or challenge the patent's validity.
For Patent Portfolio Managers
Integrating KR20080065662 into broader patent families and monitoring jurisdictional equivalents enhances regional and global enforcement strategies.
Conclusion
Patent KR20080065662 embodies a strategic pharmaceutical patent framework with a potentially broad scope, focusing on specific compounds or formulations crucial for competitive advantage in South Korea. Its claims, structured to protect core innovations, both facilitate and challenge market entry, emphasizing the importance of precise claim drafting and comprehensive patent landscaping.
Key Takeaways
- Strict Claim Definition: The patent’s scope hinges on the precise language of its claims, influencing enforceability and market exclusivity.
- Patent Positioning: Broad claims covering core compounds or formulations provide strategic dominance but must withstand validity challenges.
- Landscape Analysis: Positioning within a wider patent family enhances protection, especially if counterparts file internationally.
- Regulatory Consideration: Patent life in South Korea aligns with standard timelines; regulatory delays can impact effective protection.
- Strategic Monitoring: Continuous monitoring of patent status and potential infringers ensures sustained market control.
FAQs
Q1: How does the scope of KR20080065662 influence potential generics entering the market?
A: Broad claims covering active compounds or formulations serve as barriers, requiring competitors to design around the patent or challenge its validity.
Q2: Can the patent claims be expanded or narrowed over time?
A: Typically, claims are fixed upon grant, but patent holders can file divisional or continuation applications for broader or more specific coverage.
Q3: What are common challenges to the validity of patents like KR20080065662?
A: Prior art, obviousness, or lack of inventive step can be grounds for invalidation if claims are too broad or not sufficiently novel.
Q4: How important is patent landscaping for pharmaceutical companies?
A: It assists in assessing freedom-to-operate, identifying licensing opportunities, and developing strategies for patent filing and defense.
Q5: What is the significance of patent family subsidiaries related to KR20080065662?
A: They provide regional protection, enabling the patent holder to enforce rights and prevent infringement across multiple jurisdictions.
References
- Korean Intellectual Property Office (KIPO). Patent publication KR20080065662.
- World Intellectual Property Organization (WIPO). Patent family data and global filings.
- South Korean patent law and practice guidelines.
- Industry reports on pharmaceutical patent strategies in South Korea.
- Patent analysis literature and best practices.
Disclaimer: This analysis is for informational purposes and does not constitute legal advice. For specific patent litigation or enforcement strategies, consulting with a patent attorney is recommended.
